Rumi Scientific is a cutting-edge biotech company based in New York, NY, dedicated to revolutionizing the early stage of drug discovery for neurodevelopmental diseases. Their advanced predictive models of the human brain enable the identification of new targets and drugs, addressing the lack of treatments and de-risking the current approach.
With a disruptive platform that leverages the power of phenotype mining and artificial intelligence, Rumi Scientific is at the forefront of improving small molecule drug discovery. Their high-throughput organoid-like platform, known as neuroloids, mimics the development of the human brain, allowing for the identification and quantification of differences between diseased and healthy cells. This innovative technology predicts the therapeutic effect of potential drugs on diseased brain tissues, paving the way for novel discoveries in the treatment of genetic diseases.
Generated from the website